首页 | 官方网站   微博 | 高级检索  
     

特应性皮炎的治疗进展:新药物、新手段、新模式
引用本文:宋志强,王欢.特应性皮炎的治疗进展:新药物、新手段、新模式[J].中华皮肤科杂志,2021,54(2):161-164.
作者姓名:宋志强  王欢
作者单位:陆军军医大学西南医院皮肤科,重庆400038
摘    要:特应性皮炎是一种反复发作的炎症性皮肤病,现有的治疗方法虽能缓解症状,但仍存在一定的局限性及不良反应。近年来,随着特应性皮炎关键炎症分子的发现和靶向治疗药物的开发,给临床带来一些新的治疗方法和理念。了解特应性皮炎相关生物制剂、小分子药物、辅助治疗、监测手段和疾病管理模式新进展,有助于临床医生更好地治疗及管理特应性皮炎患者...

关 键 词:皮炎,特应性  治疗  受体,白细胞介素4  Janus激酶类  抗体,单克隆  度普利尤单抗
收稿时间:2020-10-21

Advances in the treatment of atopic dermatitis:new medications,new methods and new models
Song Zhiqiang,Wang Huan.Advances in the treatment of atopic dermatitis:new medications,new methods and new models[J].Chinese Journal of Dermatology,2021,54(2):161-164.
Authors:Song Zhiqiang  Wang Huan
Affiliation:Department of Dermatology, The Southwest Hospital of Army Medical University, Chongqing 400038, China
Abstract:Atopic dermatitis is a recurrent inflammatory skin disease.Although the existing systemic and topical treatment can relieve symptoms,there are still some limitations and adverse effects.In recent years,with the in-depth study on the pathogenesis of atopic dermatitis,especially the discovery of key inflammatory molecules and development of targeted therapeutic drugs,some new therapeutic methods and concepts have been brought to clinical practice.Awareness of new progress in atopic dermatitis-related biologics,small-molecule drugs,adjuvant treatment,monitoring methods and models for managing disease,will help clinicians better treat and manage atopic dermatitis.
Keywords:Dermatitis  atopic  Therapy  Receptors  interleukin-4  Janus kinases  Antibodies  monoclonal  Dupilumab
本文献已被 维普 等数据库收录!
点击此处可从《中华皮肤科杂志》浏览原始摘要信息
点击此处可从《中华皮肤科杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号